Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Part of paid clinical trials in Victor, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT07682831
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Basal Cell Carcinoma of Skin
- Squamous Cell Carcinoma (Skin)
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Two photon microscopy imaging — DEVICEEx vivo tissues will be imaged with two-photon microscopy and analyzed with machine learning for diagnosis
Study Details
The goal of this study is to investigate the ability of a machine learning model to evaluate two-photon fluorescence microscopy images of dermatologic biopsies at point of care. The main question it aims to answer is: • How well do two-photon fluorescence images of biopsies taken in a clinic and evaluated by a machine learning model agree with conventional histology?
Key Dates
- Start date
- Jun 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Jun 1, 2027
- Completion
- Jul 1, 2027
Study Design
- Enrollment
- 92 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: TPFM imaging of biopsySpecimens will be imaged with TPFM and diagnosed using a machine learning model
Primary Outcome Measure
Sensitivity of Machine Learning Analysis of Two Photon Fluorescence Microscopy Images At Point of Care [ Time Frame: During or immediately following patient biopsy (same day) ]
Central Contacts
- Michael Giacomelli, Ph.D5852766260
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rochester Dermatologic Surgery | Victor | New York | 14654 |
Find similar trials in Victor, NY
Related Studies
- A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · AstraZeneca · Grand Rapids, Michigan